Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morning vs Evening Dosing of Travoprost/Timolol in Glaucoma or Ocular Hypertension
NCT00759239Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Sep 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of travoprost + timolol in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Sep 2008; status: completed.
02
Drugs
travoprost + timolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00759239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00759239.